DuRoss Amy
SEC Form 4 insider trading activity
DuRoss Amy has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Oct 9, 2026.
On the most recent filing, DuRoss Amy is listed as Director at BIOLIFE SOLUTIONS INC. Inside the rolling window, DuRoss Amy reported no open-market purchases and 6 open-market sales totaling $306K in BLFS. The largest disclosed transaction in the window is a sale of 4,523 BLFS shares on Nov 20, 2025, worth $111K.
Companies traded
Other insiders at BLFS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$306K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DuRoss Amy made?
DuRoss Amy has filed 5 SEC Form 4 filings (8 transaction rows) across 1 company since 2025.
Which companies does DuRoss Amy trade?
DuRoss Amy has filed SEC Form 4 disclosures for 1 company, including BLFS.
When was DuRoss Amy's most recent SEC Form 4 filing?
DuRoss Amy's most recent SEC Form 4 filing on Tracefour is dated Oct 9, 2026.
What is DuRoss Amy's total buy and sell value in the current window?
Inside the rolling retention window, DuRoss Amy bought $0 and sold $306K based on SEC Form 4 filings.
What was DuRoss Amy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,523 BLFS shares on 2025-11-20, worth $111K, per SEC Form 4 filings.